monitoring for metabolic acidosis in patients taking topiramate (Topamax)
February 2004
Janssen-Ortho just issued a new warning about monitoring for metabolic acidosis in patients taking topiramate (Topamax).
There have been 5 cases already reported in Canada.
This is not limited to patients taking Topamax for seizures.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive